| Factor Information | |
|---|---|
| Data ID | 1967 |
| Factor | predictor of mortality: Anti-coagulant |
| Description | As for the all-cause mortality, age, NYHA class, peak VO2, arterial oxygen saturation, uses of diuretics and anti-coagulants, and low FPG were associated with the mortality. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | To clarify the prognostic value of AGR in ACHD. |
| p Value | 0.032 |
| HR | 3.07 |
| Conclusion | As for the all-cause mortality, age, NYHA class, peak VO2, arterial oxygen saturation, uses of diuretics and anti-coagulants, and low FPG were associated with the mortality. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 571 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
| Reference | |
|---|---|
| PMID | 24780541 |
| Year | 2014 |
| Title | Low fasting plasma glucose level predicts morbidity and mortality in symptomatic adults with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | blood | |
| Region | Osaka, Japan | |
| Method | univariate cox model | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac intervention and medical therapy | |
| Group | all ACHD(Treatment) | healthy(Control) |
| Number | 444 | 27 |
| Age | N/A | N/A |
| Gender (Male: Female) | 233:211 | 12:15 |
| Marker Level | N/A | N/A |
